Free Trial
NASDAQ:IMCC

IM Cannabis (IMCC) Stock Price, News & Analysis

IM Cannabis logo
$1.91 +0.15 (+8.52%)
Closing price 05/23/2025 03:57 PM Eastern
Extended Trading
$1.91 +0.00 (+0.05%)
As of 05/23/2025 07:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IM Cannabis Stock (NASDAQ:IMCC)

Key Stats

Today's Range
$1.74
$2.10
50-Day Range
$1.33
$1.91
52-Week Range
$1.29
$4.49
Volume
52,342 shs
Average Volume
36,971 shs
Market Capitalization
$4.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

Receive IMCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter.

IMCC Stock News Headlines

The “black glass” breakthrough behind AI’s next leap
AI is advancing fast… But there’s one problem almost no one’s talking about. Power.
IM Cannabis Provides Corporate Updates
See More Headlines

IMCC Stock Analysis - Frequently Asked Questions

IM Cannabis' stock was trading at $2.33 at the start of the year. Since then, IMCC stock has decreased by 18.0% and is now trading at $1.91.
View the best growth stocks for 2025 here
.

IM Cannabis Corp. (NASDAQ:IMCC) announced its quarterly earnings data on Thursday, May, 15th. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.25) by $0.31. The business had revenue of $8.69 million for the quarter, compared to analyst estimates of $11.45 million. IM Cannabis had a negative net margin of 25.55% and a negative trailing twelve-month return on equity of 129.86%.
Read the conference call transcript
.

IM Cannabis shares reverse split on Friday, July 12th 2024. The 1-6 reverse split was announced on Friday, July 12th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, July 12th 2024. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IM Cannabis investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET), GE Aerospace (GE) and AppLovin (APP).

Company Calendar

Last Earnings
5/15/2025
Today
5/24/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMCC
Fax
N/A
Employees
340
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,040,000.00
Pretax Margin
-29.52%

Debt

Sales & Book Value

Annual Sales
$54.03 million
Price / Cash Flow
N/A
Book Value
$4.55 per share
Price / Book
0.42

Miscellaneous

Free Float
2,100,000
Market Cap
$4.26 million
Optionable
Not Optionable
Beta
1.10
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:IMCC) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners